EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 0.7806
March 31, 2026 0.9387
December 31, 2025 0.7166
September 30, 2025 1.924
June 30, 2025 2.692
March 31, 2025 2.889
December 31, 2024 3.334
September 30, 2024 5.042
June 30, 2024 3.886
March 31, 2024 4.078
December 31, 2023 3.990
September 30, 2023 2.286
June 30, 2023 2.949
Date Value
March 31, 2023 2.921
December 31, 2022 3.594
September 30, 2022 3.968
June 30, 2022 4.352
March 31, 2022 5.119
December 31, 2021 5.329
September 30, 2021 5.984
June 30, 2021 6.867
March 31, 2021 7.321
December 31, 2020 8.520
September 30, 2020 7.068
June 30, 2020 4.911
March 31, 2020 2.773

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Merck & Co., Inc. 1.251
Viatris, Inc. -0.3572
Pfizer Inc. 0.7552
Pacira Biosciences, Inc. 0.3471
Bristol Myers Squibb Co. 4.539